A Non-Endoscopic Dynamic Nomogram for Atrophic Gastritis Risk Stratification Based on Serum Indicators and Clinical Factors
Journal of Inflammation Research · 2026-09 · Volume 19 · 1-11
DOI: 10.2147/jir.s636426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Ziyi Fang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy Center, Shaoxing Second Hospital, Shaoxing, Zhejiang, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Atrophic gastritis (AG) is a key precancerous lesion in gastric carcinogenesis, underscoring the need for non-endoscopic screening tools to improve early detection. This study aimed to develop a predictive model for AG based on serum indicators and clinical factors.
Methods
This single-center retrospective study enrolled 520 patients who underwent gastroscopy with biopsy at Shaoxing Second Hospital between January 2023 and December 2025. AG severity was classified via the Kimura-Takemoto system (no/mild: C0-C1, n=349; moderate/severe: C2-C3 and O-type, n=171). Multivariate analysis was performed to identify independent predictors. The performance of the resulting predictive model was evaluated, and decision curve analysis was used to evaluate the clinical utility across a range of threshold probabilities. An interactive dynamic nomogram was created for real-time risk calculation.
Results
Multivariate analysis identified four independent predictors of moderate/severe AG: older age (OR = 1.082, P < 0.001), elevated neutrophil count (NE) (OR = 2.036, P = 0.043), decreased fibrinogen (FIB) (OR = 0.56, P < 0.001), and elevated carcinoembryonic antigen (CEA) (OR = 1.171, P = 0.011). The predictive model demonstrated good discrimination in the development cohort (AUC = 0.780) and was further evaluated in an independent 94-patient inter-campus cohort (AUC = 0.705), confirming its discriminatory ability within the same hospital system.
Conclusion
This non-endoscopic model incorporating age, NE, FIB, and CEA provides a practical tool for AG risk stratification, As a single-center retrospective model, it requires further multi-center prospective validation before clinical implementation; nevertheless, it may help guide endoscopic surveillance decisions and contribute to the early prevention of gastric cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endoscopy Center, Shaoxing Second Hospital, Shaoxing, Zhejiang, People's Republic of China.
- Department of Radiation Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
ORCID-Profile: Ziyi Fang, Yunjie Zhang
Zitieren
APA
Fang, Z., & Zhang, Y. (2026). A Non-Endoscopic Dynamic Nomogram for Atrophic Gastritis Risk Stratification Based on Serum Indicators and Clinical Factors. Journal of Inflammation Research, Volume 19, 1-11. https://doi.org/10.2147/jir.s636426
Vancouver
Fang Z, Zhang Y. A Non-Endoscopic Dynamic Nomogram for Atrophic Gastritis Risk Stratification Based on Serum Indicators and Clinical Factors. Journal of Inflammation Research. 2026;Volume 19:1-11. doi:10.2147/jir.s636426
BibTeX
@article{Fang2026,
author = {Fang, Ziyi and Zhang, Yunjie},
title = {A Non-Endoscopic Dynamic Nomogram for Atrophic Gastritis Risk Stratification Based on Serum Indicators and Clinical Factors},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--11},
doi = {10.2147/jir.s636426}
}
EUVIMED